SANKYO CO Aktie

36,81 EUR 0,5656%

Zu Ihrem Onlinebroker

kaufen verkaufen

SANKYO CO Aktienkurs : 08:07 ( 15 Min. verzögert)
36,81 € Letzter Kurs	0,57% Veränderung	36,60 € Vortag	36,81 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
36,81 - 36,81 Tag	40,69 - 33,98 52 Wochen	0 Tag	1 Ø 52 Wochen	36,71 200 Stücke	38,17 200 Stücke

SANKYO CO Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

Alle SANKYO CO Aktie News auf börsennews.de

zur Übersicht der SANKYO CO Aktie

22.05.

DAIICHI SANKYO CO : Daiichi Sankyo and the National Cancer Center Form ...

Tokyo, Japan (May 22, 2012) - The National Cancer Center (Chief Director: Dr. Tomomitsu Hotta) and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo; President & Representative Director:…
21.05.

ArQule, Daiichi Sankyo complete patient recruitment in phase III MARQUEE trial ...

ArQule Inc., a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics, and Daiichi Sankyo Co., Ltd. have completed the patient recruitment in randomized, double-blind, controlled phase III ...

18.05.

ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase ...

WOBURN, MA, USA & TOKYO, Japan I May 18, 2012 I ArQule, Inc. (Nasdaq: ARQL) and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that recruitment of patients has been completed in the randomi…
18.05.

ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase ...

ArQule, Inc. (Nasdaq: ARQL) and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivota…
11.05.

Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention ...

MELBOURNE, AUSTRALIA, May 11, 2012 (MARKETWIRE via COMTEX) -- Biota Holdings Limited (asx:BTA) today announced that Daiichi Sankyo Co., Ltd. have provided written confirmation that Inavir(R) gross sales were JPY8.7bn and indicative royalties were $3.4 ...

weitere News, die den SANKYO CO Aktienkurs bewegen

Der SANKYO CO Aktienkurs im Vergleich:
Das börsennews.de-Chartalbum

SANKYO CO Jobangebote

Keine Jobangebote für SANKYO CO vorhanden

Unterhaltungselektronik

SHARP Aktie

POKERTEK Aktie

GRAVITY Aktie

NET DRAGON WEBSOFT Aktie

IEC PROFESSIONAL MEDIA Aktie

Diskutieren Sie den SANKYO CO Aktienkurs mit anderen Börsianern.

kommentieren